Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer ; volume:8 ; number:1 ; day:23 ; month:11 ; year:2018 ; pages:1-9 ; date:12.2018
Scientific reports ; 8, Heft 1 (23.11.2018), 1-9, 12.2018
- Creator
-
Thaper, Daksh
Vahid, Sepideh
Kaur, Ramandeep
Kumar, Sahil
Nouruzi, Shaghayegh
Bishop, Jennifer L.
Johansson, Martin
Zoubeidi, Amina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-35612-z
- URN
-
urn:nbn:de:101:1-2019010302341329940866
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Thaper, Daksh
- Vahid, Sepideh
- Kaur, Ramandeep
- Kumar, Sahil
- Nouruzi, Shaghayegh
- Bishop, Jennifer L.
- Johansson, Martin
- Zoubeidi, Amina
- SpringerLink (Online service)
Other Objects (12)
Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling
Metformin inhibits melanoma cell metastasis by suppressing the miR-5100/SPINK5/STAT3 axis
Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators
MiR-618 suppresses the proliferation, invasion, and migration of non-small lung cancer via the JAK2/STAT3 axis
Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Flavokawain C inhibits glucose metabolism and tumor angiogenesis in nasopharyngeal carcinoma by targeting the HSP90B1/STAT3/HK2 signaling axis
Clinical Pharmacokinetic Studies of Enzalutamide
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia
Osthole inhibits triple negative breast cancer cells by suppressing STAT3
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling
Metformin inhibits melanoma cell metastasis by suppressing the miR-5100/SPINK5/STAT3 axis
Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators
MiR-618 suppresses the proliferation, invasion, and migration of non-small lung cancer via the JAK2/STAT3 axis
Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Flavokawain C inhibits glucose metabolism and tumor angiogenesis in nasopharyngeal carcinoma by targeting the HSP90B1/STAT3/HK2 signaling axis
Clinical Pharmacokinetic Studies of Enzalutamide
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia
Osthole inhibits triple negative breast cancer cells by suppressing STAT3
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling
Metformin inhibits melanoma cell metastasis by suppressing the miR-5100/SPINK5/STAT3 axis
Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators
MiR-618 suppresses the proliferation, invasion, and migration of non-small lung cancer via the JAK2/STAT3 axis
Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Flavokawain C inhibits glucose metabolism and tumor angiogenesis in nasopharyngeal carcinoma by targeting the HSP90B1/STAT3/HK2 signaling axis
Clinical Pharmacokinetic Studies of Enzalutamide
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia
Osthole inhibits triple negative breast cancer cells by suppressing STAT3